The development of single-cell RNA-Sequencing (scRNA-Seq) has allowed high resolution analysis of cell type diversity and transcriptional networks controlling cell fate specification. To identify the transcriptional networks governing human retinal development, we performed scRNA-Seq over retinal organoid and in vivo retinal development, across 20 timepoints. Using both pseudotemporal and cross-species analyses, we examined the conservation of gene expression across retinal progenitor maturation and specification of all seven major retinal cell types. Furthermore, we examined gene expression differences between developing macula and periphery and between two distinct populations of horizontal cells. We also identify both shared and species-specific patterns of gene expression during human and mouse retinal development. Finally, we identify an unexpected role for ATOH7 expression in regulation of photoreceptor specification during late retinogenesis. These results provide a roadmap to future studies of human retinal development, and may help guide the design of cell-based therapies for treating retinal dystrophies.
To comprehensively profile gene expression changes across retinal development, we performed scRNA-Seq on dissociated retinas from both human retinal organoids and primary tissues. To profile very early stages of retinal development, we profiled human retinal organoids, generated as previously described (Eldred et al., 2018) , at 24, 30, 42 and 59 days in vitro. These timepoints correspond to early retinogenesis in vivo for which we were unable to procure samples, and include developmental windows of the earliest RPCs and initial RGC differentiation. Strikingly, a majority of the cells from organoids Days 24-42 in culture (13552/19861; 68.2% ; Table S1 ) were annotated as non-eye-field cells due to expression of ventral forebrain and hypothalamic markers (FOXG1, NKX2-1, DLX5, ARX, LHX6; (Shimogori et al., 2010) ) and lack of expression of eye-field specification markers (VSX2, PAX6, RAX, and LHX2) . In addition, we generated profiles from whole developing retinas obtained at 9, 11, 12, 13, 14, 15, 16, 17, 18, 19, 22, 24, and 27 gestational weeks (GW) , macular and peripheral samples from 20 gestational weeks and 8 days postnatal (PND), and whole retina from a healthy 86 year old donor ( Fig. 1A; Fig S1A, Table S1 ). Samples were profiled to a mean depth of 3472.61 unique molecular identifiers (UMIs; standard deviation = 1862.78) and 1502.14 genes (standard deviation = 589.41) per cell ( Fig. S1A-C) . These samples were then integrated using Monocle 2.99.3 and UMAP dimension reduction on high variance genes to obtain a 3dimensional embedding of retinal development ( Fig. 1B,C; Fig. S1D ,E; Movie S1-2; Table S2 ) (Becht et al., 2018; Qiu et al., 2017) . Major cell types were annotated using previously identified marker genes (Blackshaw et al., 2004; Clark et al., 2019; Macosko et al., 2015; Siegert et al., 2012) expressed within clusters of cells in the dimension reduction space (Fig. S1F,G) .
Although these data were obtained from three different sources (Fig. S1A ), involving different dissociation techniques, this nonetheless yielded an integrated cell distribution and set of developmental trajectories that broadly resemble those seen in mouse . Two major classes of RPCs are observed, which match the previously described primary and neurogenic subtypes in mouse . Differentiating Müller glia form a continuous developmental trajectory that emerges from the primary RPCs, while all retinal neurons emerge from the neurogenic fraction. As in the mouse, three major neuronal trajectories are observed: RGCs, amacrine and horizontal interneurons, and rods, cones and bipolar cells, respectively ( Fig 1B-C; Fig S1D-E ; Movie S2). RPCs and RGCs from organoids seamlessly integrate into this distribution, comprising the earliest developmental ages. Unlike in the mouse, we observed a distinct trajectory of human horizontal cells, likely due to the substantially increased abundance of captured horizontal cells within this dataset compared to mouse (5.8% in human versus 1.5% in mouse).
We next compared the fraction of each progenitor and postmitotic cell type observed at each time point to that in mouse ( Fig. 1D,E; Fig. S1F -G) , and observed a broadly similar pattern of temporal windows for cell type specification. In both species, RGCs predominate early, with cones and horizontal cells being generated shortly thereafter. Peak relative numbers of rods and amacrine cell generation occurred near the midpoint of neurogenesis, while bipolar and Müller glial cells emerged last (Fig. 1D ). In humans, however, a broader temporal distribution of cone and horizontal cell generation was observed. Additionally, we examined the ages at which primary RPC, neurogenic RPC, and cell type precursors are observed across the human and mouse scRNA-Seq datasets, highlighting temporal windows of amacrine, horizontal, bipolar, and photoreceptor cell specification windows (Fig. 1E ).
We next identified selective markers of each major progenitor and postmitotic cell type by feature ranking in clustered single cell data using genesorteR (Ibrahim and Kramann, 2019) (Fig. 1F ). This revealed known and novel markers of specific cell types. While most show identical cell-type specificity in both mice and humans, additional or entirely novel patterns of cell-specific expression were evident in some cases. For instance, in mice, the lipid-binding protein CLU is selectively expressed in Müller glia (Blackshaw et al., 2004) , but in humans it is strongly expressed in both primary RPCs and Müller glia. In contrast, while retinoid binding protein CRABP2 is expressed exclusively in early-stage primary RPCs in mouse , it is also strongly expressed in human cone precursors. Other examples of coneenriched genes in humans that show different patterns of expression in mouse include DCT, which is restricted to the retinal pigmented epithelium in mouse, and HOTAIRM1, which is not detectably expressed in mouse retina (Fig. 1F ). Other differences include human-specific genes, such as RAX2, which we detected in both cone and rod photoreceptors. Immunohistochemical analysis demonstrates that protein expression patterns of known marker genes also broadly reflect cell-specific and temporally dynamic patterns of transcript expression detected by scRNA-Seq ( Fig. 1G-L; Fig. S1H-N) .
Early and late-stage human RPCs show distinct gene expression profiles
Previous scRNA-Seq analysis of mouse retinal development identified clear transcriptional signatures of early and late-stage primary RPCs , reflecting differential expression of genes that control proliferation, neurogenesis, and cell fate determination. To determine the extent of evolutionary conservation in temporal patterning of RPCs, we conducted pseudotemporal analysis of gene expression changes across primary RPCs and Müller glia. Interestingly, organoid-derived RPCs displayed gene expression patterns of early-stage RPCs from primary tissue ( Fig. 2A-C) . Pseudotemporal ordering of RPCs identified bimodal densities of RPCs across pseudotime, followed by Müller glia that reflected the sequential developmental ages of input tissue ( Fig. 2A-C; S2A,B ). This mirrored changes observed in mouse, although the transition between early and late-stage RPCs occurred more gradually. In mice, the transition between early and late-stage RPCs occurs rapidly between E16 and E18, but in humans this process occurs between 11 and 15 gestational weeks (GW), and likely reflects the regional differences in developmental human retina development between central and peripheral regions (Diaz-Araya and Provis, 1992; van Driel et al., 1990) . The fraction of human RPCs in G1 is increased relative to mouse (p < 0.0001; chi-squared test; Fig. S2C ), which may reflect the much longer time course of retinal neurogenesis seen in humans relative to mice (Centanin and Wittbrodt, 2014) .
We observed similar expression of markers for early and late-stage primary RPCs in human as in mouse, including SFRP2 and NFIA (Fig. 2D; Fig. S2G ). Likewise, many of the genes upregulated in Müller glia begin their expression in late-stage primary RPCs (i.e RLBP1, NFIB) . Unlike the Müller glia-specific expression pattern seen in mice (Blackshaw et al., 2004; Reichenbach and Bringmann, 2013) , however, both CLU and VIM are expressed in primary RPCs at all stages of neurogenesis ( Fig. 1F; Fig. 2D ). Known inhibitors of the WNT pathway (SFRP1 and FRZB) are expressed in early RPCs, and then again specifically in Müller glia at later stages. Immunohistochemistry revealed that expression of RLBP1 is observed in KI67 + mitotic late-stage RPCs in central retina by 12 GW and displays a more developmentally delayed peripheral retinal expression by 16 GW (Fig. 2E,F; Fig. S2D ). The loss of MKI67 and RLBP1 co-localization coincided with the emergence of co-localization of SOX2 and RLBP1 in Müller glia ( Fig. 2G; Fig. S2E-F) .
Neurogenic RPCs are observed in all samples except the Day24 organoids and PND8 samples ( Fig. 2H -J, Tables S1), and pseudotemporal ordering of neurogenic RPCs reflected transcriptional signatures of age-matched primary RPCs. Neurogenic RPCs likewise showed broadly similar temporal expression patterns in humans as in mice (Fig. S2H ). As in mouse, a subset of human genes show selective expression in either early or late-stage neurogenic RPCs (Fig. 2J,K; Fig. S2H ). However, pseudotime analyses did not reveal a clear signature of early and late-stage human neurogenic RPCs as observed in mouse ( Fig. S2J-K ; ). Genes that display temporal enrichment in early-stage neurogenic RPCs in both humans and mice include DLX1/2, GAL, ONECUT2, and ATOH7, while genes enriched in late-stage neurogenic RPCs include ASCL1, OTX2, and SOX4 (Fig. 2K; Fig. S2H) . A handful of genes, however, showed substantial species-specific differences in expression. Several genes that are expressed across neurogenic RPC development in mouse --such as OLIG2, NEUROG2, and BTG2 --display higher expression in late-stage human neurogenic RPCs (Fig. S2I ). Moreover, C8ORF46 (3110035E14Rik; Vexin), which is selectively expressed in early-stage neurogenic RPCs in mouse Moore et al., 2018) , is also expressed in late-stage neurogenic RPCs in humans ( Fig. S2I ). A small number of genes that lack mouse orthologs, including HES4, are also enriched in human neurogenic RPCs (Fig. S2I ). As in primary RPCs, a greater fraction of human neurogenic RPCs are in G1 than in mouse (p < 0.0001; Chi-square test), and the fraction of cells in G1 increases steadily over the course of neurogenesis ( Fig.  S2L ).
Identification of differentiation trajectories for each major human retinal cell type
To identify gene regulatory networks that control retinal cell specification and differentiation, we independently conducted pseudotime analysis along the cellular trajectories of each major retinal cell type ( Fig. 3; Fig. S3 ). We observed many transcription factors that show highly-specific expression at various stages of differentiation of each cell type in humans, display similar expression in mouse. Both human and mouse retinal ganglion cells express the well-characterized transcript markers POU4F1, POU4F2, POU6F2, ISL1, NHLH2, RXRG, EBF1 and EBF3 (Clark et al., 2019; Rheaume et al., 2018; Tran et al., 2019) (Boije et al., 2016; Clark et al., 2019) , and show considerable overlap in transcription factor expression with amacrine cells ( Fig. 3I-L) . However, differentiating human starburst amacrine cells (SACs) selectively express NEUROG3, which is not expressed in mouse retina in any cell type, but human SACs also express canonical transcription factors SOX2, ISL1, and FEZF1 ( Fig. S3A -C) (Balasubramanian and Gan, 2014; Clark et al., 2019) .
Some of the more pronounced differences in transcription factor expression between human and mouse are observed in differentiating photoreceptors. In the mouse, ISL2 is strongly expressed in retinal ganglion cells, but only weakly expressed in cone photoreceptors (Triplett et al., 2014) . In both humans and chick, however, (Edqvist et al., 2006; Triplett et al., 2014) , ISL2 is strongly expressed in human cones, along with its cofactor LMO4 ( Fig. 3M -P). The Kruppel class zinc finger transcription factor HKR1, which is selectively expressed in developing human rods, is entirely absent from the mouse genome. Strikingly, ATOH7 is also expressed in human photoreceptor/bipolar precursors and immature cones ( Fig. 3Q -T), in sharp contrast to the mouse and also every other species examined to date, where it is preferentially expressed in early-stage neurogenic RPCs (Brown et al., 1998; Kanekar et al., 1997; Kay et al., 2001) . These findings imply the existence of species-specific differences in the transcriptional regulatory networks controlling rod and cone photoreceptor specification.
Since we observed a organoid-specific cone trajectory in our dimension reductions ( Fig.  1B-C) , we next performed the same pseudotemporal analysis on organoid versus in vivo cone development,. This analysis of gene expression identifies some unexpected differences in the differentiation of cone photoreceptors in retinal organoids relative to primary tissue ( Fig. S3D-F ). While organoid derived cones express substantially lower levels of cone precursor-enriched transcription factors such as CRX, the organoid-derived cones also express neurogenic factors typically associated with non-photoreceptor cell types including LHX9, NHLH1, and SOX11. Subsets of organoid-derived cones, however, do express additional cone photoreceptorenriched genes. These include THRB, ISL2, LMO4, RXRG, SALL3 and DCT. Therefore, as indicated by the relative position of the organoid-cone trajectory within the dimension reduction, the organoid-derived cones more closely resemble native cones than any other cell type, (Fig. 1B-C; Movie S1-2).
While we identified many transcripts/transcription factors as differentially expressed across the pseudotemporal analyses of individual cell trajectories ( Fig. 3, Fig. S3 ), it should be noted that many of the genes are not specific to any one cell trajectory ( Fig. S3G ), suggesting that many transcription factors regulate specification of multiple cell types.
Central vs. peripheral differences in retinal transcript expression
To identify regional differences in gene expression associated with the development of the macula compared to the peripheral retina, we examined differential gene expression between macula and peripheral cells from the GW20 and PND8 retinal samples using the `fit_models` function from Monocle3. We observed broad transcriptional differences between the regions within individual cell types ( Fig. S4 A-I); however, analyses are partially confounded by cell type capture efficiencies inherent to the datasets. Furthermore, since macular retina is developmentally advanced relative to peripheral retina (Diaz-Araya and Provis, 1992; van Driel et al., 1990; La Vail et al., 1991) , we examined the correlation of differentially expressed transcripts with pseudotime trajectories across each individual cell type ( Fig. S4 J-Q). The correlation with pseudotime helps to distinguish bona fide enrichment in cells in macular retina from simple differences in developmental age between macular and peripheral retina. The pseudotime analyses suggest many of the observed regional differences are correlated (both positively and negatively) with cell type differentiation and maturation. However, other transcripts, such as the cone macula-enriched transcript DST display little correlation with pseudotime, and may reflect true regional differences.
We identified multiple genes that were differentially expressed between macular and peripheral RPCs that showed little correlation with pseudotime (correlation close to 0; Fig S4Q) . These include CYP26A1, DIO2, CDKN1A, ANXA2, and FRZB ( Fig. 4A; Fig. S4J -Q). Of particular interest is CYP26A1, a transcript implicated in marking a rod-free zone in the chicken (da Silva and Cepko, 2017) , and selectively expressed in RPCs and Müller glia of both the developing and mature primate fovea (Cowan et al., 2019; Peng et al., 2019) . We then validated enrichment of CYP26A1 and DIO2 transcript expressions and co-expression of SFRP1 or RLBP1 within macula cells of the GW18 retina ( Fig 4B-C) . This allowed us to extrapolate the expression of any of the 5 listed marker genes to the rest of the RPCs within the dataset to identify additional potential macular RPCs within whole retina dissociations ( Fig. 4D ). Subsequent differential tests were performed on the inferred macular/peripheral primary RPCs using a regression model to reduce the effect of cell cycle phase on differential gene expression. Our results highlight additional potential candidate regulators of macula development. Sample and cell type specific enrichment of the candidate regulators is shown in Figures 4E-F, many of which are enriched in RPCs and Müller glia. One interesting candidate macula development regulator gene enriched in our macular RPC population is CTGF. CTGF is a downstream target of the Hippo signaling pathway. While CTGF displays enriched expression within Müller glia, recent studies have identified a FGF15 (19 in humans)/FGFR4-mediated pathway for Hippo-pathway activation (Ji et al., 2019) . Since FGF19 expression marks early RPCs, activation of Hippo-signaling and degradation of retinoic acid (CYP26A1 expression) may function concordantly to confer macular specialization. Macula-enriched expression is observed for genes expressed in all major cell types ( Fig. 4F; Fig. S4J -Q). Comparison of genes enriched in developing human macula with foveal-enriched genes from adult macaque retina reveals that CYP26A1 and CTGF are enriched in Müller glia in both species, as are RBP3 and PROM1 in cones, and VTN in rods (Peng et al., 2019) .
Specification and differentiation of two human horizontal cell subtypes.
While mouse retinas contain a single subtype of horizontal cell, primate retinas contain at least two distinct subtypes. Recent scRNA-Seq analysis of macaque retina identified two horizontal cell subtypes distinguished by the presence or absence of CALB1 expression (Peng et al., 2019) . Our analysis of human horizontal cell precursors also clearly identifies two subtypes of differentiating horizontal cells, distinguished by differential expression of the LIM homeodomain transcription factors LHX1 and ISL1 ( Fig. 5A-C; Fig. S5F ). Using smfISH, we confirm that LHX1+ and ISL1+ horizontal cells are distinct populations ( Fig. 5D -H), but that both express the pan-horizontal cell markers ONECUT1-3 ( Fig. S5A -C; G,H). The presence of ISL1+ horizontal cells in humans is similar to the chicken, where 2 populations of Isl+ horizontal cells with distinct morphology are observed (Suga et al., 2009) . The ISL1+ horizontal cells are also CALB1+, likely corresponding to the previously identified CALB1+ horizontal cells of macaque ( Fig. S5D) (Peng et al., 2019) . However, since all horizontal cells are both Lhx1+ and Calb1+ in mouse (Boije et al., 2016; Clark et al., 2019; Lo Giudice et al., 2019) , this represents a major species-specific difference in gene expression. Differential expression and pseudotemporal analyses identify additional markers of these horizontal subtypes, including PCDH9, C1QL1, and SOSTDC1 for LHX1+ cells and FAM135A and SYNPR for ISL+ horizontal cells ( Fig. 5I; Fig.  S5E ,I). The two populations of horizontal cells also show different expression of cell surface receptors. LHX1+ cells specifically expresses the dopamine receptor DRD2, while no other dopamine receptor genes are expressed in either horizontal cell population ( Fig. 5I ). LHX1+ cells also express MEGF11, which has been shown to regulate mosaicism of horizontal cells in mouse (Kay et al., 2012) , suggesting that an alternative mechanism is likely used to form ISL1+ horizontal cell mosaics ( Fig. 5I ).
Identification of convergent and divergent gene expression patterns in mouse and human retina using scCoGAPS and projectR
To identify gene regulatory networks in human retinal development, we used scCoGAPS on 3113 transcripts displaying high variance across the dataset (Table S2 ), identifying 112 patterns of gene co-expression in our human scRNA-Seq data . Through projectR, we then projected our previously published mouse retinal development scRNA-Seq dataset, excluding all non-neuroretinal cells, onto these 112 human retinal patterns Stein-O'Brien et al., 2019) . By analyzing associations between each pattern and each main retinal cell types in both human and mouse datasets, we were able to identify patterns that are divergent or convergent between the two species ( Fig. 6A ; Fig. S6 A-D). In general, most patterns highly correlated with individual cell types showed broadly similar cellular expression patterns in both species. However, several patterns stood out as highly divergent, particularly patterns correlated with human cone development. One example of divergent patterns between mouse and human is Human Pattern 75, which marks human cones but highlights both early RPCs and cones in mouse ( Fig. 6A -D; Fig. S6A ,C). Examination of the top marker genes of human Pattern 75 indicate that the divergence between the species is driven by transcripts that include CRABP2, DCT, and LOXL1 (Fig. 6E ). Specifically, human LOXL1 is expressed in developing neurons, with high expression in cones and developing rods ( Fig. 6F ). In contrast, mouse Loxl1 shows little expression within the developing retina, being detected in only a few early-stage RPCs (Fig. 6G ).
We also identified 97 gene patterns across 3164 highly variable genes within the neuroretinal cells from the mouse scRNA-Seq dataset (Table S2 ) and repeated the same comparison process Stein-O'Brien et al., 2019) . Of note, 753 of the >3000 highly variable were used as input to scCoGAPS across both species. A similar overall picture was seen in mouse, with patterns displaying high correlation with individual cell types corresponding to the same cell type in humans. Some patterns displayed low correlation with cell types across the species (Fig. 6H ; Fig. S6E -H). Notable among these is Pattern 20, which in mouse is enriched in late-stage RPCs but in human is enriched in rods, cones and late-stage RPCs ( Fig. 6H -K; Fig. S6E ,G). Tubb4b, a marker for Pattern 20, shows substantial differences in cellular expression levels in late-stage RPCs, rods and cones in humans and mice ( Fig. 6L-N) . These unbiased cross-species analyses highlight both similarities and disparities in gene usage across mouse and human retinal development, in particular in the control of photoreceptor specification and differentiation, and can be used to identify instances where mouse models may not recapitulate human disease.
ATOH7 controls the relative ratio of human rod and cone photoreceptors
Multiple lines of evidence from this study suggest that the gene regulatory networks controlling photoreceptor development differ substantially between mouse and humans. We identified ATOH7 expression in late-stage neurogenic RPCs and immature cones, in addition to its expression in early-stage neurogenic RPCs, which has been observed in every other species examined to date ( Fig. 7A; Fig. S7A ,B) (Brown et al., 1998; Kanekar et al., 1997; Kay et al., 2001; Matter-Sadzinski et al., 2001) . This was confirmed using immunostaining for ATOH7 and the early photoreceptor-enriched markers OTX2 and CRX. At both early and late stages of photoreceptor development, we observe fraction of both OTX2 ( Fig. 7B ,C; Fig. S7E ) and CRXpositive cells ( Fig. 7D ,E; Fig. S7F ) that also express ATOH7. This colocalization was temporally dynamic and showed major differences between central and peripheral retina. Nearly 10% of all OTX2+ cells in central retina were also ATOH7-positive at GW10, but at later stages very little colocalization was observed ( Fig. 7C ). In contrast, at stages examined between GW10 and GW20, 12-20% of all OTX2-positive cells in peripheral retina were also ATOH7-positive. Colocalization of ATOH7 and CRX also showed a large difference between central and peripheral retina, with very little observed in central retina, but more than 30% of CRX-positive cells in peripheral retina expressing ATOH7 at GW14, though with the fraction of co-expressing cells declining rapidly thereafter to undetectable levels at GW22 (Fig. 7E) .
These results imply that ATOH7 might act selectively in humans to promote the specification and/differentiation of cones in the peripheral retina. To directly test whether ATOH7 regulates human photoreceptor genesis, we co-transduced GW17-19 explants with lentiviral vectors that express control or ATOH7 shRNA together with GFP or RFP, respectively ( Fig. 7F) . Quantifying control and test shRNA transduced cells in the identical retinal fragment avoids the confounding effects of positional variation in developmental stage. We confirmed efficient depletion by shATOH7 vectors relative to a scrambled (shSCR) control ( Fig. S7E ,F). Explants were assessed 21-23 days after co-transduction. Cone and rod proportions were quantified in control and test cells using positive and negative labeling in the ONL for one of two cone markers (RXRγ or GNAT2) or a rod marker (NRL), and the cone-rod ratio in shATOH7 cells relative to shSCR cells was calculated. Irrespective of which of the three staining methods was used, depleting ATOH7 with either of two separate shRNAs reduced cones in favour of rods ( Fig. 7G ,H; Fig. S7G -J). Depleting ATOH7 did not affect overall photoreceptor numbers because the ratio of ONL proportions in shATOH7 vs. shSCR was 1 ( Fig. 7I ). Together, these data indicate that ATOH7 promotes cone genesis in the human fetal retina.
Discussion:
Our transcriptomic analysis using both embryonic stem cell-derived retinal organoids and primary tissue at single-cell resolution encompasses nearly the full time-course of human retinal development. While bulk RNA-Seq of the developing human retina and scRNA-Seq of human retinal organoids are already available, they have important limitations (Collin et al., 2019; Hoshino et al., 2017; Hu et al., 2019; Mellough et al., 2019) ). Bulk RNA-Seq cannot resolve cell-type specific changes in gene expression. Furthermore, the extent to which retinal organoids fully recapitulate in vivo development at the individual cell level is still not entirely clear (Cowan et al., 2019) . The combinatorial use of scRNA-Seq and human developing retinal tissue in our dataset overcomes some of these limitations. Combined, the dataset offers a valuable resource for identifying the gene regulatory networks that occur in human retinal development. Using this dataset in parallel with data previously generated from mouse Lo Giudice et al., 2019) can highlight similarities and discrepancies across evolution, and help determine whether specific mouse models are actually relevant to human retinal disease. Furthermore, these findings open new avenues of research with respect to spatial patterning, cell fate specification, and the function of individual neuronal subtypes of the human retina.
This analysis identified some major differences between the gene expression pattern of immature cones analyzed in human retinal organoids and primary tissue ( Fig. S3A -C). We hypothesize that this difference results from the abrupt changes in culturing conditions with the addition or subtraction of growth factors, signaling pathway inhibitors, or oxygen during the human retinal organoid culturing process. One of these treatments, in particular, is the addition of the gamma-secretase and Notch-pathway inhibitor DAPT from days 29-45 of organoid culture to assist with photoreceptor specification (Jadhav et al., 2006; Wahlin et al., 2017; Yaron, 2006) . Interestingly, 92.7% (1591 of 1716) of organoid-derived cones in our dataset were derived from organoids within this treatment window (i.e. 30 or 42 days in culture organoids). This suggests that while the treatment of organoids with DAPT does stimulate photoreceptor specification, the differentiation trajectory of these organoid-derived cones varies markedly from that seen in vivo, even though more mature organoid-derived cones and native cones eventually show broadly similar gene expression profiles (Cowan et al., 2019) .
Human retinal neurogenesis occurs over a much longer interval than in mouse. While many of the identified cell-type specific markers and differentially expressed genes across the developmental trajectory of each major retinal cell type are conserved in mouse, there are still some major differences. For example, Clu is specific to Müller glia in mice, but is expressed in both RPCs and Müller glia in human. Interestingly, a previous study has shown that Clu+ revival stem cells in the intestine are multipotent, capable of giving rise to the major cell types of the intestine and transiently expanding in a YAP1 dependent manner (Ayyaz et al., 2019) . Since Clu is strongly expressed in both human RPC and Müller glia, it is possible that manipulating the YAP1 pathway will induce the regenerative pathway of human Müller glia. Consistent with this, two recent papers have implicated Hippo pathway signaling in regulating Müller glial quiescence, and YAP overexpression was sufficient to induce Müller glia to reenter the cell cycle (Hamon et al., 2019; Rueda et al., 2019) . A number of genes, including several transcription factors such as HES4 and HKR, show highly cell type-specific expression in human retina, but are absent from the mouse genome altogether. This raises the question of whether these genes are used in regulating human-specific aspects of retinal development, or have simply taken over evolutionarily-conserved functions carried out by related genes in mice.
The presence of the fovea is perhaps the most obvious anatomical difference between the retinas of primates and other mammals. We found differentially expressed genes between peripheral and macular RPCs and Müller glia, allowing us to elucidate the molecular underpinnings of cone-rich foveal formation. One of the genes examined, CYP26A1 (retinoic acid-metabolizing enzyme), is conserved in chicken, and is important for creating a rod free zone by catabolizing retinoic acid (da Silva and Cepko, 2017) . This suggests that conserved mechanisms inhibiting the retinoic acid signaling pathway are involved in the formation of a high-acuity, cone-rich, rod-free zone. Other genes that are strong candidates for controlling foveal development that are both enriched in these cells and not strongly positively correlated with pseudotime include DIO2, which promotes differentiation of L/M cones at the expense of Scones (Eldred et al., 2018) , the Wnt pathway inhibitors SFRP2 and FRZB, and secreted antiproliferative factors such as CTGF and PTN. Wnt signaling acts during early stages of retinal development to inhibit central retinal identity (Cho and Cepko, 2006; Liu et al., 2007) , and its presence here suggests that it may play an analogous role in control of foveagenesis. Antiproliferative factors such as CTGF and PTN may mediate the early cessation of proliferation seen in the foveal region (Diaz-Araya and Provis, 1992; van Driel et al., 1990) , although the fact that CTGF expression is also enriched foveal Muller glia in adult macaque suggests that it may also have other functions related to controlling mature glial function or morphology (Peng et al., 2019) . The coordinated action of these signaling pathways in RPCs may provide the initial signals that pattern the fovea. Finally, macular-enriched expression of a number of genes encoding cell adhesion and extracellular matrix components (ITGB1, COL1A2, ITM2B) is observed in RPCs and MG, suggesting that these may be candidates for morphogenesis of the foveal pit. Although macular-enriched genes that are not positively correlated with pseudotime are found that are enriched in multiple neuronal cell types, including several that are enriched in both developing photoreceptors of the human macula and adult macaque fovea (Peng et al., 2019) , their function is less clear, and awaits direct functional analysis.
Similar to previous studies in macaque and adult humans, we also observed two subtypes of horizontal cells in human retina, consistent with those classified in previous studies of macaque retina (Peng et al., 2019) . Although morphological studies of adult human retina have identified three distinct subtypes of horizontal cells (Kolb et al., 1994) , we only observed clear evidence for two. In humans, these two subtypes express different combinations of neurotransmitter receptor genes. Most prominently, LHX1+ horizontal cells specifically express dopaminergic receptor DRD2 while no other dopaminergic receptor genes are expressed in either horizontal cell subtypes. While dopaminergic amacrine cells are thought to be the only retinal cells that produce dopamine, we detected weak expression of the dopamine transporter SLC6A3 in both rods and bipolar cells. The expression of DRD2 on LHX1+ horizontal cells and potential dopamine transporter transcript expression in rods and bipolar cells, therefore, implies that LHX1+ horizontal cells may selectively respond to a dopamine signal within the rod spherule.
We also observed that ISL1+/CALB1+, unlike Lhx1+, horizontal cells lack MEGF11 expression. MEGF11 regulates homotypic repulsion of horizontal cells in mouse (Kay et al., 2012) . Since retinal subtypes are frequently spaced evenly across the retina, but randomly positioned with respect to other subtypes (Rockhill et al., 2000) , it will be interesting to identify the determinants of ISL1+ horizontal cell retinal mosaic spacing independent of MEGF11 and define these novel mechanisms of horizontal cell homotypic repulsion in the developing human retina. Other evolutionary differences we observe include the re-emergence of LHX1+ and CALB1+ horizontal cells in primate retinas (Peng et al., 2019) , whereas the genes are colocalized in the single type of mouse horizontal cell. Since chickens also possess distinct populations of Isl1+ and Lhx1+ horizontal cells, with two morphologically distinct populations of Isl1+ cells (Suga et al., 2009) , we hypothesize that nocturnal rodents consolidated these populations to one cell type. Further examination of number of cellular subtypes within the retina across evolutionarily divergent species will address whether or not the number of horizontal cell subtypes directly correlates with the number of cone subtypes.
To examine gene regulatory networks in an unbiased manner and without a priori knowledge of gene interactions, we used scCoGAPS pattern identification and ProjectR latent transfer learning. These tools provide a robust, transferable way for comparing genecoexpression networks across species Stein-O'Brien et al., 2019) . These techniques identified patterns of gene expression that were both shared and divergent across species. Furthermore, these analyses highlighted genes such as LOXL1, implicated in pseudoexfoliation syndrome (Thorleifsson et al., 2007) , to have distinct expression patterns across human and mouse retinal development. This not only implies that pseudoexfoliation syndrome may present with a retinal pathology during development, but also highlights some of the unexpected pitfalls of modelling human diseases in mice. Divergent patterns between the two species also raises the question of what are the evolutionary drivers behind these divergences. In human corticogenesis, it has been hypothesized that coordinated changes in regulatory domains of co-expressed genes drive cortical evolution (Reilly et al., 2015) . This is further highlighted by large transcriptional differences observed in brain cell type evolution across the primate lineage, despite little sequence divergence in protein coding genes (Khrameeva et al., 2019) . Hence, it is possible that the divergent expression patterns of conserved genes across human and mouse retinal development corresponds to changes in the use and/or sequence of transcriptional regulatory elements.
Finally, we examined the role of ATOH7 within late developmental periods of retinogenesis. Patients with mutations within the ATOH7 coding or regulatory sequences exhibit persistent fetal vasculature (PFV) and/or nonsyndromic congenital retinal nonattachment (NCRNA), respectively (Ghiasvand et al., 2011; Prasov et al., 2012) . Both of the diseases, however, are associated with defects in RGC development. Here, we show ATOH7 is also involved in the specification of late-born cones, suggesting alterations in the proportion of cones to rods may also be observed in patients with either PHPV or NCRNA. Atoh7 mutant mice generate additional cones at the expense of RGCs (Brown et al., 2001) , although atoh7 zebrafish mutants retinas exhibit no change in cone development (Kay et al., 2001) . Together, these data suggest ATOH7 may have different mechanisms of function in retinal cell fate determination across evolution. The exquisite sensitivity or resistance of RB1-deficient human or murine cones to tumorigenesis reflects the intrinsically high expression of oncogenes such as MDM2 and MYCN specifically in human cells (Xu et al., 2009) . Our results highlight a fundamental difference between the mechanisms by which human and mouse cones are specified, which presumably influences the resulting cone circuitry and, therefore, susceptibility to RB1 loss.
The rapid improvement of techniques for the culturing of human ES and iPS-derived retinal organoid preparations makes it feasible to directly study the functional role of candidate extrinsic and intrinsic regulators of human retinal development identified in this study. While functional studies using human retinal organoids have thus far largely focused on analysis of evolutionarily conserved gene regulatory networks (Eldred et al., 2018) , they provide an accessible and tractable system for studying aspects of retinal development that cannot be readily modelled in mice and early fetal development. The combinatorial application in organoid preparations of growth and differentiation factors identified in our study has the potential to highlight molecular signals that are sufficient to induce foveagenesis. Coupled with the use of CRISPR-mediated knockout approaches, this will lead to direct functional tests of human retinal genes that lack mouse orthologs or show markedly different expression patterns in developing retina.
Goat polyclonal anti-Sox2
Santa Cruz Cat# sc17320; RRID:AB_2286684 RNAscope® Probe-Hs-CYP26A1 ACD Cat#487741
RNAscope® Probe-Hs-SFRP1-C2 ACD Cat#429381
RNAscope® Probe-Hs-RLBP1-C2 ACD Cat#414221-C2
RNAscope® Probe-Hs-DIO2-C3 ACD Cat#562211-C3
RNAscope® Probe-Hs-LHX1 ACD Cat#493021
RNAscope® Probe-Hs-ISL1-C2 ACD Cat#478591-C2 FitzSimmons et al., 1994; Shepard, 1975) . Eye samples collected were held on ice for up to 6 hour in the retina culture medium, which is IMDM with 10% FBS and 1X Antibiotic-Antimycotic (Life Technologies, Cat#15240062). US Sample: The use of human globes obtained from Tissue Banks was approved by the Johns Hopkins Institutional Review Board.
Preparation of Retinal Organoids
Retinal organoids were prepared as described (Wahlin et al., 2017) 
Retinal Dissociation for single cell sequencing
Canadian Samples: Developing eyes at gestational ages week 9 to week 19 were sterilized in 70% ethanol for 3 seconds, rinsed twice in cold phosphate-buffered saline (PBS) (Wisent Bioproducts, Cat#311-010-CL), and transferred to IMDM for retinal dissection. Retinas were dissociated with Papain Dissociation System (Worthington Biochemical, Cat# LK003150). Briefly, retinas were incubated in papain solution for about 15 minutes at 37°C and 5% CO2, with gentle pipetting every 5 minutes. With dissociation to ~20-cell clusters, cells were suspended in 10 volumes of sterile phosphate buffered saline (PBS), pelleted by centrifugation at 300 x g for 10 minutes, and re-washed with PBS, followed by digestion with 0.05% trypsin/EDTA (Wisent Bioproducts, Cat# 325-042-EL) with gentle pipetting to produce single cell suspension, washed with 10 volumes of retina culture medium, and resuspended in proper volumes of the culture medium for single cell sequencing procedure. Cell viability (>90%) was confirmed by negative staining with trypan blue (Life Technologies, Cat#15250061). Single cell libraries were then prepared using the 10x Single Cell 3' v2 Reagent Kits according to the manufacturer's instructions and sequenced on an Illumina NextSeq500 using recommended sequencing parameters (Read 1 -26bp; Read 2 -98bp; i7 Index -8bp; i5 Index -0).
Chinese Samples: Gestational age was measured in weeks from the first day of the woman's last menstrual cycle to the sample collecting date. Developing retinal tissue samples were collected in ice-cold artificial cerebrospinal fluid (ACSF) containing 125.0 mM NaCl, 26.0 mM NaHCO3, 2.5 mM KCl, 2.0 mM CaCl2, 1.0 mM MgCl2, 1.25 mM NaH2PO4; pH 7.4, bubbled with 95% O2/5% CO2. The retina macula samples (2mm) were defined by lack of vascular. Whole retinal samples were gently separated into small pieces and then centrifuged at 200g for 2min. The supernatant was removed and 500ul digestion buffer (2mg/ml collagenase IV (Gibco), 10 U/μl DNase I (NEB), and 1mg/ml papain (Sigma) in PBS) was added. The tissue was then rotated and incubated at 37°C on a thermo cycler with 300g for 15-20 min. Samples were triturated every 5 min to digest the tissue sample into single cell suspensions. Finally, inactivation of enzymatic digestion was induced through the addition of an equivalent volume of 10% fetal bovine serum (Gibco) in PBS. Cells were pelleted and resuspended in 0.04% BSA/PBS and stained with 7-amino-actinomycin D (7-AAD) for 10 min on ice in order to check for cell viability. 7-AAD-negative cells were collected by FACS and resuspended in 0.04% BSA/PBS. Single cell libraries were then prepared using the 10x Single Cell 3' v2 Reagent Kit according to the manufacturer's instructions and sequenced on an Illumina HiSeq4000 with 150bp paired-end reads.
US Samples:
Retinal organoids were processed as described in Clark et al., 2019. Multiple organoids were pooled and placed in 200μl of cold HBSS per organoid, with an equivalent amount of Papain dissociation solution (for 1ml -100μl freshly prepared 50mM L-Cysteine (Sigma), 100μl 10mM EDTA, 10μl 60mM 2-mercaptoethanol (Sigma), and Papain added to 1mg/ml (Worthington), to 1ml with reagent-grade water). Organoids in dissociation solution were then placed at 37C for 10 minutes, with slight trituration every 1-2 minutes. Enzymatic digestion was halted with addition of 600μl Neurobasal Medium supplemented with 10% FBS for every 400μl of HBSS/dissociation solution. 5μl/organoid DNaseI (RNase free Recombinant DNaseI; Roche) was added and incubated 5-10 minutes at 37C. The dissociation solution was then gently triturated using a P1000 pipette tip and cells were pelleted through centrifugation for 5 minutes at 300RCF. Supernatant was carefully aspirated off the cell pellet, followed by resuspension of the cellular pellet in 1-5ml Neurobasal media with 1% FBS. Cellular aggregates were removed by straining cells through a 50μm filter. Single-cell libraries were then prepared using the 10x Single Cell 3' v2 Reagent Kits according to the manufacturer's instructions and sequenced on an Illumina NextSeq500 using recommended sequencing parameters (Read 1 -26bp; Read 2 -98bp; i7 Index -8bp; i5 Index -0).
Human adult retinal sample:
A human globe from an 86 year old Caucasian female who died of a myocardial infarction and had no known ocular disease other than cataracts, was obtained from the Alabama Eye Bank (Birmingham, AL) and processed within 3.3 hours after death. The study was approved by the Johns Hopkins Institutional Review Board. To dissect the neural retina. the anterior segment was first removed by incising the scleral behind the limbus, to remove the anterior parts, lens and vitreous body. The neural retina was then peeled off from the eyecup, and retinal cells were dissociated using Papain Dissociation System (Worthington Biochemical, Lakewood, NJ) following the manufacturer's instructions. Dissociated cells were resuspended in ice-cold PBS, 0.04% BSA and 0.5 U/UL of RNAse inhibitors. Cells were then filtered through a 50um filter.
Library preprocessing
Resulting sequencing outputs were processed through the CellRanger2 mkfastq and count pipelines using default parameters. Transcript reads were quantified using the 10x Genomics Human reference index (refdata-cellranger-GRCh38-3.0.0). Cells were then given unique, sample-specific cell identifiers to prevent duplicate cell names in the aggregate dataset from reuse of barcodes across samples.
Aggregation of Datasets, initial processing and cell type assignment
Human retinal organoids: Resulting count matrix files from Cellranger alignments/counting of retinal organoids were imported and aggregated in Monocle2 R/Bioconductor (Qiu et al., 2017) . First, cells with > 40,000 Total_mRNAs were removed as outliers. We then identified genes with high biological coefficient of variation by first normalizing sequencing depth across all organoidderived cells using the Waddington-OT transformation to transcript copies per 10,000 (CPT) (Schiebinger et al., 2019) and then using a generalized additive model (MGCV R package; (Wood et al., 2015) ) fit to the log2 mean CPT versus a cubic spline fit to the log2 coefficient of variation across all genes with detectable expression in >10 cells. Transcripts that displayed >1.1 residual to the fit were chosen as 'high-variance' genes. Dimension reduction was then performed on the resulting 2441 high variance genes (Table S1 ) using the first 24 principal components as input into largeVis dimension reduction (Tang et al., 2016) . Cell type annotation of Retina/RPE versus non-Retina was performed using eye-field marker genes including RAX, PAX6, and VSX2 while excluding markers of ventral telencephalon and hypothalamus, including NKX2.1, DLX5 and DLX6. The resulting 11,758 cells Retinal/RPE cells of the original 25,461 organoid cells were then used for aggregation with the in vivo samples.
Human retinas: All 20 samples of primary retinal tissue were manually aggregated from the individual Cellranger matrix files, resulting in 113,999 individual cells. Initial processing proceeded as above with the following differences: 1) Cells with >10,000 Total_mRNAs were removed, 2) A residual cutoff for determination of high variance genes was set at 1.15, resulting in 2719 highly variable genes that were used for input into dimension reduction, 3) the first 17 dimensions were used as input to PCA, and 4) dimension reduction was performed using UMAP within the `reduceDimension` function of Monocle3alpha, with the following parameters: max_components = 3, metric= 'canberra', min_dist = 0.34, n_neighbors = 50, residualModelFormulaStr = "~Total_mRNAs + sample", random_state = 123456L. The resulting 3-dimensional structure was clustered using the `clusterCells` function of Monocle3alpha with the following parameters: use_pca = FALSE, k=15,res=4.0e-4, method = 'louvain', gaussian = TRUE, louvain_inter=5, set.seed(123456). Preliminary cell type annotation was performed based on cluster markers from the `find_cluster_markers` function and examination of expression of known marker genes within the individual clusters. Non-retinal derived cells (microglia, vasculature, etc.) and annotated doublets (identified through incompatible gene expression) were removed from the cell dataset at this time, resulting in an accumulated cell total of 107,013 in vivo retinal cells.
Final aggregation: Cell datasets from the organoids and in vivo retinas were merged to create a single cell dataset. We again removed cells with >10,000 Total_mRNAs, thus reducing the final dataset to 11,542 organoid-derived cells and 107,013 human retina-derived cells (118,555 total cells). The same exact dimension reduction parameters were used for the total aggregate as the in vivo retinas, using the high variance genes from the in vivo developing retina dataset. Clustering on the 3-dimensional UMAP was performed using `clusterCells` function of Monocle3alpha using the following parameters: use_pca = FALSE, k=15,res=1.0e-3, method = 'louvain', gaussian = TRUE, louvain_inter=5, set.seed(123456). Determination of corresponding cell type of clusters was performed based on marker gene expression as previously described. Cell cycle phase of primary and neurogenic RPCs was determined using the `CellCycleScoring` function of Seurat.
Immunohistochemistry of retinal tissue
Human retina tissue samples were fixed overnight in 4% paraformaldehyde. The fixed retinas were dehydrated in 20% and 30% sucrose in PBS at 4 o C and embedded in optimal cutting temperature medium (Thermo Scientific). Thin 20-40μm cryosections were collected on superfrost slides (VWR) using a Leica CM3050S cryostat. For immunohistochemistry, antibodies against the following proteins were used at the following dilutions: Goat anti-SOX2 . Primary antibodies were diluted in blocking buffer containing 10% donkey serum, 0.2% Triton X-100 and 0.2% gelatin in PBS at pH 7.4. Alexa Fluor 488, Alexa Fluor 594 or Alexa Fluor 647 fluorophore-conjugated secondary antibodies (1:500) (Life Technologies) were used as appropriate. Cell nuclei were stained with DAPI (1:10000). Images were collected using an Olympus FV1000 confocal microscope.
RNAscope
RNAscope® detection was performed in strict accordance with the ACD RNAscope® protocol (Wang et al., 2012) . Briefly, retina sections were dehydrated in sequential incubations with ethanol, followed by 30 min Protease III treatment and washing in ddH2O. Appropriate combinations of hybridization probes were incubated for 2 hours at 40°C, followed by fluorescence labeling, DAPI counterstaining, and mounted with Prolong Gold mounting medium.
Diffusion Pseudotime & Trajectory Analysis
We exported the cell dataset matrices used in Monocle to create an object to perform pseudotime in Scanpy v1.4 (Wolf et al., 2018) .The dataset was subset to relevant cell types based on the desired analysis, with cells from samples displaying significant batch effects (Hgw12) or discontiguous trajectories in UMAP dimension reductions -likely resulting from gaps in sampling ages (Hpnd8 and Adult) -removed from the analyses. High variance genes used as input to Scanpy are listed in Table S2 for each cell type analysis. Diffusion Pseudotime was used to reconstruct the trajectory from least mature cells to final cell fate(s) as previously described (Haghverdi et al., 2016; Wolf et al., 2018) . Batch effect corrections, if necessary, were conducted prior to determination of highly variable genes, unless the BBKNN test was used (Polański et al., 2019) . The parameters used for assigning pseudotime values within Scanpy are listed in Table S3 .
Corresponding pseudotime values from scanpy were assigned to cells within the Monocle cell dataset. Differential genes across pseudotime were assessed using the `differentialGeneTest` function in Monocle, requiring that all differential transcripts being expressed in >= 10 cells. The following parameters were used for the differential gene test: 1) if one terminal cell fate, fullModelFormulaStr= "~sm.ns(Pseudotime,df=3)" 2) if multiple terminal cell fates, fullModelFormulaStr = "~sm.ns(Pseudotime,df=3)*Branch" and reducedModelFormulaStr = "~sm.ns(Pseudotime,df=3)". If needed, known batch effects were included in the differential gene test parameters as previously described (Qiu et al., 2017; Trapnell et al., 2014) . For analyzing the trajectories from retinal progenitor cells to Müller Glial or Neurogenic Cells, cell cycle was regressed from the expression matrix using Seurat v3.0 to assign Cell Cycle Scores and Phase as previously described (Butler et al., 2018) . These scores and phase were assigned to corresponding cells within the Monocle cell dataset. Cell Cycle Scores were regressed within the `preprocessCDS` function (Qiu et al., 2017; Trapnell et al., 2014) . Differential gene expression across pseudotime analysis was then conducted on the regressed expression matrix as described above.
Annotation of retinal progenitor cell subtypes
Examination of the density of RPCs across pseudotime identified two clear density peaks. We annotated early versus late RPCs based on positioning across the pseudotime axis in relation to the trough between the peaks (dotted line - Fig. S2A ; pseudotime value of 0.4609), with early RPCs corresponding to pseudotime values ≤ 0.4609 and late RPCs corresponding to pseudotime values >.04609.
scCoGAPS pattern discovery
Human Patterns: scCoGAPs analysis was performed on all retinal cells excluding the adult retinal samples. The large expression matrix size (33,694 genes by 118,555 cells) was subset down to a set of 3113 (Table S2 ) highly variable genes that excluded both mitochondrial and ribosomal protein coding genes. This down-sampling of genes allowed both faster implementation of scCoGAPS and was implemented to reduce the number of patterns that highlight sample batch effects of cellular stress or read depth. The log2 transformation of the expression matrix was used as input into the scCoGAPS function from CoGAPS v3.5 as previously described Stein-O'Brien et al., 2019) . The parameters were default singleCell parameters, except nPatterns=100, nIterations=500, sparseOptimization = True, seed =830, nSets=27 (~3960 cells/set) with annotation weights set to sample underrepresented cell types more.
Mouse Patterns: We used scCoGAPS from CoGAPS v3.5 to reanalyze the mouse retinal development dataset from Clark et al., 2019 , but limited the dataset to include only the retinal cells. We used 3164 high variance genes across the dataset, again excluding mitochondrial and ribosomal genes and used nSets = 25 (4414 cells/set).
Comparisons of pattern usage across species
To examine the extent to which human or mouse patterns corresponded to similar biological processes in the opposite species, we used projectR to project the log2 of the scRNA-Seq expression matrix into the scCoGAPS pattern amplitude matrix . The Ensembl database from BioMart was used to identify the corresponding homologs of the pattern genes (Durinck et al., 2005 (Durinck et al., , 2009 . As some mouse genes had multiple human homologs, the pattern weights of each of these human orthologs are combined by taking the maximum value. If a human gene had multiple mouse orthologs, the same gene weights were reused between the mouse orthologs.
The same process was used to determine mouse patterns and the projections of their use in human data matrix, except 3164 highly variable mouse genes were used, nSets=25 (4414 cells/set), and gene names were capitalized to find human orthologs.
Construction of shATOH7 lentiviral vectors
To suppress ATOH7 expression in developing human retina, pLKO.1-TRC cloning vector (Moffat et al., 2006) was purchased from Addgene (Cat#10878). The puromycin selection marker in the vector was replaced with GFP-P2A-Puromycin or RFP-P2A-Puromycin ORF cassette with Gibson Assembly Master Mix (New England Biolabs, Cat#E2611L) to generate pLKO.1-GFP-P2A-Puro or pLKO.1-RFP-P2A-Puro cloning vector. Specific cloning details are available on request. The target sequence for scrambled shRNA is CCTAAGGTTAAGTCGCCCTCG available from Addgene (Cat#1864) (Sarbassov et al., 2005) , and the sequences of the hairpin pair are as follows:SCR-F: CCGGCCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGGTTTTTG; SCR-R: AATTCAAAAACCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG.
The target sequence for shATOH7-1 is GTGAAGTTACAGTATCCATTA available from TRC library database (TRCN0000423538) (Moffat et al., 2006) , and the sequences for the hairpin pairs are as follows:
shATOH7-1F: CCGGGTGAAGTTACAGTATCCATTACTCGAGTAATGGATACTGTAACTTCACTTTTTTGAAT;
shATOH7-1R: AATTCAAAAAGTGAAGTTACAGTATCCATTACTCGAGTAATGGATACTGTAACTTCAC.
The target sequence for shATOH7-2 is GATTCTCAGATTACCTTTATT designed with an online tool (http://www.broad.mit.edu/genome_bio/trc/rnai.html) (Moffat et al., 2006) , and the sequences of the hairpin pair are as follows:
shATOH7-2F:
CCGGGATTCTCAGATTACCTTTATTCTCGAGAATAAAGGTAATCTGAGAATCTTTTTG;
shATOH7-2R:
AATTCAAAAAGATTCTCAGATTACCTTTATTCTCGAGAATAAAGGTAATCTGAGAATC.
Both shRNAs are targeted to the 3′UTR of ATOH7 gene. The oligos of the hairpin pairs were purchased from Eurofins Genomics, annealed together, and cloned into AgeI and EcoRI cloning sites of pLKO.1-GFP-P2A-Puro or pLKO.1-RFP-P2A-Puro vector with Quick Ligation Kit (New England Biolabs, Cat#M2200S) (Moffat et al., 2006) .
Production of shATOH7 lentivirus and virus validation
Lentivirus was produced with Lenti-X 293T packaging cells (Clontech, Cat#632180) transfected with viral vectors and packaging plasmids pMD2.G and psPAX2 (Addgene, Cat#12259 and Cat#12260) in DMEM medium (Wisent Bioproducts, Cat#319-005-CL) supplemented with 10% fetal bovine serum (FBS) (Wisent Bioproducts, Cat#080-150) (Sanjana et al., 2014) . Briefly, for each virus, 5 X 10 6 cells were seeded in a 10-cm plate the day before transfection. On the day of transfection, culture medium was removed and replaced with 5 ml of prewarmed fresh medium. A mixture of 3 μg viral vector, 2.25 μg pPAX2, 0.75 μg pMD2.G and 18 ul of Lipofectamine 2000 (Life Technologies, Cat#11668019) in 3.0 ml of Opti-MEM I Reduced-Serum Medium (1X) (Life Technologies, Cat#31985070) was added dropwise to the cells with gentle mixing by rocking the plate back and forth. The culture medium with transfection reagent was removed 12 hours later, and replaced with 10 ml of warm fresh medium. Virus-containing supernatants were harvested 48 hours after transfection, filtered through a 0.45 μm low protein binding membrane (Sarstedt, Cat#83.1826), and concentrated with Lenti-X Concentrator (Clontech, Cat#631231) according to the inserted protocol. Virus pellets were dissolved in 100 μl of IMDM (Wisent Bioproducts, Cat#319-105-CL), aliquoted and stored at -80°C.
For validation, a developing human cone cell line was generated by transduction of human retina with shRB1 virus and selection for replicating cells. Identity was validated with multiple cone markers, then cells were transduced with shATOH7 lentivirus for 8 days. To assess ATOH7 knockdown efficiency, RNA and protein were extracted from the cells, and Real-Time qRT-PCR as well as Western blot were carried out as described previously (Chen et al., 2009) to measure ATOH7 expression. Human β-ACTIN and TBP (TATA-Box Binding Protein) were used as qRT-PCR references, and β-ACTIN was used as a loading control for Western blot ( Figure S7 ). The PCR primers are the following.
ATOH7-F: AGTACGAGACCCTGCAGATG ATOH7-R: TGGAAGCCGAAGAGTCTCTG β-ACTIN-F: AAAGCCACCCCACTTCTCTCTAA β-ACTIN-R: ACCTCCCCTGTGTGGACTTG TBP-F: ATGTTGAGTTGCAGGGTGTG TBP-R: CAGCACGGTATGAGCAACTC
Transduction of developing human retinal explants with shATOH7 lentivirus
Developing human retinas at gestational age from GW17 to GW19 were sterilely dissected in IMDM and cut radially. Tissue fragments were transferred on to cell-culture inserts (Millpore, Cat#PICM03050) with photoreceptor side down (Jin and Xiang, 2012) . Inserts with retinal fragments were quickly put in 6-well plates with 1300 μl of prewarmed retina culture medium, and incubated at 37°C with 5% CO2. Due to spatiotemporal difference in developing human retina development (Hoshino et al., 2017) , each explant culture was co-transduced with both control and treatment viruses by adding freshly thawed virus mixture on top of retinal fragment ( Figure 1A) . The explants were cultured for about 3 weeks, and the medium was changed twice per week, with half of the culture medium replaced with fresh medium.
Immunofluorescence staining and microscopy of retinal explants
After about 3 weeks of culture, the retinal explants were fixed with 4% paraformaldehyde overnight at 4°C, washed 3 times with cold PBS, dehydrated in 30% sucrose for 24 hour at 4°C, 26 embedded in 30% sucrose/OCT compound (1:1), and stored at -80°C. The frozen tissue blocks were sectioned at 16 μm thickness, and air-dried at room temperature for 4 hours, stored at -20°C. For immunostaining, sections were rinsed in Tris-buffered saline with 0.1% Tween 20 (TBS-T), incubated in blocking buffer containing 2.5% bovine serum albumin (BSA) in TBS-T for 1 hour at room temperature, and labeled with primary antibodies diluted in blocking buffer overnight at 4°C. The following day, sections were washed 3 times with TBS-T, and incubated for 1 hour at room temperature with appropriate secondary antibodies conjugated to 488/568/647 fluorophores. Subsequently, sections were washed with TBS-T for 3 times, coverslipped, mounted in VECTASHIELD Hardset Antifade Mounting Medium with DAPI (Vector Laboratories, Cat# H-1500) to counterstain nuclei, and imaged using Nikon Ti-E inverted confocal microscope. Images were processed using ImageJ (NIH). For each explant per staining, at least 10 images were processed. Cones were confirmed with RXRγ or GNAT2 staining, and rods with NRL staining. The ratios of percentages of cones versus rods in the control and treatment virus transduced photoreceptors were calculated. Antibodies were used at the following dilutions: ATOH7 -1:700, GFP -1:300 (rabbit polyclonal; Life Technologies), GNAT2 -1:100, mCherry -1:500, NRL -1:00, RFP 1:300, RXR -1:100. 1, S1, 3, S3, 5 and S5 . High variance genes used as input for dimension reductions and Scanpy analyses. Movie S1. Related to Figure 1B . Movie of the 3D-UMAP dimension reduction embedding of the developing human retina scRNA-Seq dataset with cells colored by developmental age.
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